AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Viral Hepatitis

Implementing the Viral Hepatitis Action Plan: The Role of Community Leadership

Hep B United logo

The development of the updated national Action Plan for the Prevention, Care, & Treatment of Viral Hepatitis: 2014-2016 [PDF 2.01MB] (Action Plan) in April 2014 marked a new opportunity for community-based organizations invested in eliminating hepatitis B and C disparities, to explore what activities federal agencies are planning to undertake and how the organizations and agencies…

Access to Hepatitis C Therapy Listening Session with Community Stakeholders

Ronald Valdiserri

Last month, the Department of Health and Human Services (HHS) convened a listening session on the important issue of access to curative treatment for hepatitis C virus infection. While the advent of more effective, second-generation direct-acting antivirals for the treatment of hepatitis C represents a tremendous scientific accomplishment and a potential public health triumph, community…

Viral Hepatitis Prevention Coordinators, a Vital CDC Program Helping to Achieve the Goals of the Viral Hepatitis Action Plan

CDC Logo

Viral Hepatitis Prevention Coordinators (VHPCs) are vital to the implementation of the nation’s Action Plan for the Prevention, Care, & Treatment of Viral Hepatitis, and ultimately, achievement of 3 of the national goals of reducing viral hepatitis transmission and disease: Increase the proportion of persons who are aware of their hepatitis B virus (HBV) infection,…

Viral Hepatitis Issues Examined at 2014 American Public Health Association (APHA) Annual Meeting

apha-logo

Hepatitis B and C were among the important public health issues examined at the recent annual meeting of the American Public Health Association (APHA) . The annual meeting, held November 14-19, 2014 in New Orleans, Louisiana, is one of the nation’s largest gatherings of public health professionals, including clinicians, researchers, policy makers, students, and others committed…

Looking Ahead to 2015

ron_video

As 2014 comes to a close and we prepare to celebrate the potential of the new year, Dr. Ronald Valdiserri, Deputy Assistant Secretary for Health, Infectious Diseases, shares his thoughts on the year ahead in this video message. Dr. Valdiserri, who leads efforts to implement the National HIV/AIDS Strategy and the Viral Hepatitis Action Plan,…

2014 Viral Hepatitis Year-in-Review and Looking to 2015

Ronald Valdiserri

2014 has been a year of both opportunities and challenges in the fight against viral hepatitis. In May, the World Health Assembly passed a new resolution  [PDF 151 KB] on viral hepatitis, urging member states to develop and implement coordinated, national strategies for preventing, diagnosing and treating viral hepatitis.  Our nation’s own comprehensive viral hepatitis strategy,…

FDA approves Viekira Pak to treat hepatitis C

FDA

The U.S. Food and Drug Administration today approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis. Hepatitis C is a viral disease that causes inflammation of the liver that…

Two New Hepatitis C Resources Support Expanding Provider Capacity

Ronald Valdiserri

Two professional medical societies have recently launched initiatives to support a wider variety of health care providers in adapting to new roles and opportunities resulting from the rapidly evolving arena of hepatitis C (HCV) screening, diagnosis, and treatment. As the Viral Hepatitis Action Plan observes, providers at every level in the healthcare system can play…